Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q1 FY26 results · Apr–Jun 2025
Krishna Institute of Medical Sciences reported revenue from operations of ₹871.60 crore (up 26.6% from Q1 FY25) and net profit of ₹85.00 crore (down 10.7% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 871.60 | 688.40 | +26.6% | 796.90 | +9.4% |
| Other income | 7.10 | 4.60 | +54.3% | 4.50 | +57.8% |
| Total income | 878.70 | 693.00 | +26.8% | 801.40 | +9.6% |
| Profit before tax | 113.70 | 127.10 | −10.5% | 134.00 | −15.1% |
| Net profit for the period | 85.00 | 95.20 | −10.7% | 106.10 | −19.9% |
| Attributable to shareholders of the company | 78.60 | 86.60 | −9.2% | 101.80 | −22.8% |
| EPS, basic (₹) | 1.96 | 10.82 | not comparable | 2.54 | −22.8% |
| Net margin (%) | 9.8 | 13.8 | 13.3 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 373.40 | 327.40 | +14.1% | 345.90 | +8.0% |
| Other income | 12.20 | 5.30 | +130.2% | 24.20 | −49.6% |
| Total income | 385.60 | 332.70 | +15.9% | 370.10 | +4.2% |
| Profit before tax | 79.70 | 81.60 | −2.3% | 120.60 | −33.9% |
| Net profit for the period | 58.80 | 60.70 | −3.1% | 93.60 | −37.2% |
| EPS, basic (₹) | 1.47 | 7.58 | not comparable | 2.34 | −37.2% |
| Net margin (%) | 15.7 | 18.5 | 27.1 |
Consolidated
- Filed with BSE
- 06 Aug 2025, 15:16 IST
- Board meeting
- 06 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Aug 2025, 15:16 IST
- Board meeting
- 06 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE